Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF APRIL 11, 2012 FBO #3791
SOLICITATION NOTICE

65 -- POTASSIUM IODIDE TABLETS, USP, - Solicitation 1

Notice Date
4/9/2012
 
Notice Type
Justification and Approval (J&A)
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
Defense Logistics Agency, DLA Acquisition Locations, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, Pennsylvania, 19111-5096, United States
 
ZIP Code
19111-5096
 
Solicitation Number
spm2dp11r0005
 
Archive Date
1/26/2012
 
Point of Contact
jamaal edwards, Phone: 2157374179
 
E-Mail Address
jamaal.edwards@dla.mil
(jamaal.edwards@dla.mil)
 
Small Business Set-Aside
N/A
 
Description
Justification Justification for Other than Full and Open Competition Under Authority of 10 U.S.C. 2304(c)(1) Potassium Iodide Tablets •1. The Defense Logistics Agency (DLA), Troop Support, Medical Supply Chain is the contracting activity. •2. The action being approved is the ability to solicit for DLA requirements on an Other than Full and Open Competition basis. •3. Following are the supplies required to meet DLA's needs: Item Description: Potassium Iodide Tablets, USP,130 MG, Potassium Iodide, Individually Sealed in Foil Wrap, 14s NSN: 6505-01-496-4916 Quantity: 75,000 PG Unit Price: $5.23 (Based on the award made on 6/17/11 for 175 PG.) Number of Options: None Maximum Dollar Value: $392,250.00 •4. The applicable statutory authority permitting Other than Full and Open Competition is 10 U.S.C. 2304(c)(1), FAR Part 6.302-1(c), Only one responsible source and no other supplies or services will satisfy agency requirements. •5. The use of this authority is necessary because the USAMMA has submitted a MILSTRP for this item to ensure that critical operational forces are protected in the event of nuclear fallout. The recent earthquake in Japan in March of 2011 and the resultant nuclear crisis has renewed interest in this item.. Anbex Inc. is the only FDA-approved manufacturer of the subject item. There are fourteen tablets in each package which will protect one adult for two weeks.The procurement history of the item indicated that awards were only made to Anbex Inc. and distributors offering the Anbex Inc. item. If an offer is received from a new manufacturer of this item, FDA approval will be required prior to award. The FDA recommends potassium iodide (KI) for thyroid blocking in radiation emergencies. It can be used to provide safe and effective protection against thyroid cancer caused by irradiation. •6. This requirement was synopsized on 12/12/11 and on 1/26/12 in FedBizOpps. In addition, this justification will be published with the solicitation in accordance with FAR 6.305(c). •7. As the Contracting Officer, I hereby determine that the anticipated cost to the Government will be fair and reasonable based on a comparison with Anbex Inc.'s lowest price catalog where the items are sold in substantial quantities to the general public. Negotiations will be conducted to assure that the Government receives equal to or lower than the lowest price sale to the general public under terms and conditions that are comparable to those solicited by the Government. It is anticipated that the price under this contract will represent the best value and lowest cost alternative (considering price and other factors). •8. DLA Troop Support performed market research through the internet, and DLA Troop Support Medical Supplier Operations Directorate, Pharmaceutical Manufacturer/Distributor Division, Technical/Quality Support Section. This search revealed that Potassium Iodide Tablets, USP, 130 MG of Potassium Iodide, Individually Sealed in Foil Wrap, 14s, is only available from Anbex Inc. or distributors offering the item manufactured by Anbex Inc. •9. There are no other facts supporting the use of Other than Full and Open Competition. •10. Anbex Inc. has expressed an interest in this acquisition. •11. This agency will continue to survey the market in an attempt to remove or overcome any barriers to competition and identify additional sources before any subsequent acquisitions are initiated. •12. As the Contracting Officer, I hereby certify that this justification is accurate and complete to the best of my knowledge and belief. ___________ ____________________________ Date TINA BALLEZZI Contracting Officer
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/DLA/J3/DSCP-M/spm2dp11r0005/listing.html)
 
Record
SN02717216-W 20120411/120409235009-19f566deeffa645babd1e3731b7326c6 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.